Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil

Production of extended-spectrum beta-lactamases (ESBL) by enterobacteria is an important resistance mechanism against antimicrobial beta-lactamics. We tested 498 bacterial strains isolated from two tertiary-care teaching hospitals for ESBL production, using screening breakpoints for aztreonam and th...

Full description

Bibliographic Details
Main Authors: Keite da Silva Nogueira, Ilma Hiroko Higuti, Agnaldo José do Nascimento, Larissa Bail Terasawa, Simone de Oliveira, Adriana Pereira Matos, Helena Aguilar Peres Homem de Mello de Souza, Laura Lúcia Cogo, Libera Maria Dalla Costa
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000600006&lng=en&tlng=en
_version_ 1819267546761658368
author Keite da Silva Nogueira
Ilma Hiroko Higuti
Agnaldo José do Nascimento
Larissa Bail Terasawa
Simone de Oliveira
Adriana Pereira Matos
Helena Aguilar Peres Homem de Mello de Souza
Laura Lúcia Cogo
Libera Maria Dalla Costa
author_facet Keite da Silva Nogueira
Ilma Hiroko Higuti
Agnaldo José do Nascimento
Larissa Bail Terasawa
Simone de Oliveira
Adriana Pereira Matos
Helena Aguilar Peres Homem de Mello de Souza
Laura Lúcia Cogo
Libera Maria Dalla Costa
author_sort Keite da Silva Nogueira
collection DOAJ
description Production of extended-spectrum beta-lactamases (ESBL) by enterobacteria is an important resistance mechanism against antimicrobial beta-lactamics. We tested 498 bacterial strains isolated from two tertiary-care teaching hospitals for ESBL production, using screening breakpoints for aztreonam and third generation cephalosporins, according to CLSI recommendations. Among these isolates, 155 were positive for the ESBL screening test, and 121 (78%) were confirmed by the clavulanic acid combination disk method. We found a high frequency of ESBL (24%) among Enterobacteriaceae, with a frequency of 57.4% for Klebsiella pneumoniae, 21.4% for Klebsiella oxytoca, and 7.2% for E. coli. In other members of Enterobacteriaceae, non-Klebsiella and non-E. coli, the prevalence was 21.6%. Ceftriaxone and cefotaxime showed a higher sensitivity in the screening test (99.2%) when compared to ceftazidime, aztreonam and cefpodoxime. However, cefotaxime/cefotaxime plus clavulanic acid showed a higher sensitivity in the confirmatory test (96.7%).
first_indexed 2024-12-23T21:18:54Z
format Article
id doaj.art-70e9e4e947cf40e3918c86803c1a4559
institution Directory Open Access Journal
issn 1678-4391
language English
last_indexed 2024-12-23T21:18:54Z
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-70e9e4e947cf40e3918c86803c1a45592022-12-21T17:30:49ZengElsevierBrazilian Journal of Infectious Diseases1678-439110639039510.1590/S1413-86702006000600006S1413-86702006000600006Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern BrazilKeite da Silva Nogueira0Ilma Hiroko Higuti1Agnaldo José do Nascimento2Larissa Bail Terasawa3Simone de Oliveira4Adriana Pereira Matos5Helena Aguilar Peres Homem de Mello de Souza6Laura Lúcia Cogo7Libera Maria Dalla Costa8Universidade Federal do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáPontifícia Universidade Católica do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáProduction of extended-spectrum beta-lactamases (ESBL) by enterobacteria is an important resistance mechanism against antimicrobial beta-lactamics. We tested 498 bacterial strains isolated from two tertiary-care teaching hospitals for ESBL production, using screening breakpoints for aztreonam and third generation cephalosporins, according to CLSI recommendations. Among these isolates, 155 were positive for the ESBL screening test, and 121 (78%) were confirmed by the clavulanic acid combination disk method. We found a high frequency of ESBL (24%) among Enterobacteriaceae, with a frequency of 57.4% for Klebsiella pneumoniae, 21.4% for Klebsiella oxytoca, and 7.2% for E. coli. In other members of Enterobacteriaceae, non-Klebsiella and non-E. coli, the prevalence was 21.6%. Ceftriaxone and cefotaxime showed a higher sensitivity in the screening test (99.2%) when compared to ceftazidime, aztreonam and cefpodoxime. However, cefotaxime/cefotaxime plus clavulanic acid showed a higher sensitivity in the confirmatory test (96.7%).http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000600006&lng=en&tlng=enESBLbeta-lactamasesEnterobacteriaceae
spellingShingle Keite da Silva Nogueira
Ilma Hiroko Higuti
Agnaldo José do Nascimento
Larissa Bail Terasawa
Simone de Oliveira
Adriana Pereira Matos
Helena Aguilar Peres Homem de Mello de Souza
Laura Lúcia Cogo
Libera Maria Dalla Costa
Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil
Brazilian Journal of Infectious Diseases
ESBL
beta-lactamases
Enterobacteriaceae
title Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil
title_full Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil
title_fullStr Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil
title_full_unstemmed Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil
title_short Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil
title_sort occurrence of extended spectrum beta lactamases in enterobacteriaceae isolated from hospitalized patients in curitiba southern brazil
topic ESBL
beta-lactamases
Enterobacteriaceae
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000600006&lng=en&tlng=en
work_keys_str_mv AT keitedasilvanogueira occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil
AT ilmahirokohiguti occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil
AT agnaldojosedonascimento occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil
AT larissabailterasawa occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil
AT simonedeoliveira occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil
AT adrianapereiramatos occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil
AT helenaaguilarpereshomemdemellodesouza occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil
AT lauraluciacogo occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil
AT liberamariadallacosta occurrenceofextendedspectrumbetalactamasesinenterobacteriaceaeisolatedfromhospitalizedpatientsincuritibasouthernbrazil